GILEAD SCIENCES, INC. Payments for (Proceeds from) Other Investing Activities
GILEAD SCIENCES, INC. (GILD) reported Payments for (Proceeds from) Other Investing Activities of -$3.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-06
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was -$20.00M.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $17.00M, a 26.09% decline year-over-year.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -$11.00M.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was -$4.00M.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2025 was -$2.00M.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2024 was -$58.00M, a 5900.00% decline from fiscal 2023.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2023 was $1.00M, a 0.00% change from fiscal 2022.
- GILEAD SCIENCES, INC. payments for (proceeds from) other investing activities for fiscal 2022 was $1.00M.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 3 month as first filed | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 6 month as first filed | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 9 month as first filed | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.00M 10-Q · filed 2026-08-06 | -$14.00M derived: sum of 3 quarters · filed 2026-08-06 | -$18.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $17.00M 10-Q · filed 2026-05-07 | $6.00M derived: sum of 2 quarters · filed 2026-05-07 | $2.00M derived: sum of 3 quarters · filed 2026-05-07 | -$8.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$15.00M derived: sum of 2 quarters · filed 2026-02-24 | -$25.00M derived: sum of 3 quarters · filed 2026-08-06 | -$2.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$14.00M derived: sum of 2 quarters · filed 2026-08-06 | $9.00M 10-Q · filed 2025-11-07 | -$26.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.00M 10-Q · filed 2026-08-06 | -$22.00M derived: sum of 3 quarters · filed 2026-08-06 | -$33.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $23.00M 10-Q · filed 2026-05-07 | -$12.00M derived: sum of 2 quarters · filed 2026-05-07 | -$23.00M derived: sum of 3 quarters · filed 2026-05-07 | -$30.00M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$46.00M derived: sum of 2 quarters · filed 2026-02-24 | -$53.00M derived: sum of 3 quarters · filed 2026-02-24 | -$58.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$18.00M derived: sum of 2 quarters · filed 2025-11-07 | -$23.00M 10-Q · filed 2025-11-07 | -$22.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$12.00M 10-Q · filed 2025-08-07 | -$11.00M derived: sum of 3 quarters · filed 2026-02-24 | -$17.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$5.00M 10-Q · filed 2025-05-07 | -$4.00M derived: sum of 2 quarters · filed 2026-02-24 | -$10.00M derived: sum of 3 quarters · filed 2026-02-24 | -$9.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.00M derived: sum of 2 quarters · filed 2026-02-24 | -$4.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.00M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.00M derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$2.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.00M 10-Q · filed 2024-08-08 | $4.00M derived: sum of 3 quarters · filed 2025-02-28 | $6.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-08 | $3.00M derived: sum of 2 quarters · filed 2025-02-28 | $5.00M derived: sum of 3 quarters · filed 2025-02-28 | $6.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $1.00M derived: sum of 3 quarters · filed 2025-02-28 | $1.00M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.00M derived: sum of 2 quarters · filed 2023-11-07 | $3.00M 10-Q · filed 2023-11-07 | $3.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.00M 10-Q · filed 2023-08-04 | $1.00M derived: sum of 3 quarters · filed 2024-02-23 | -$18.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $777.00M 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | -$19.00M derived: sum of 3 quarters · filed 2024-02-23 | -$110.00M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$19.00M derived: sum of 2 quarters · filed 2024-02-23 | -$110.00M derived: sum of 3 quarters · filed 2024-02-23 | -$19.00M 10-K · filed 2024-02-23 | $163.00M 10-K · filed 2022-02-23 | |||
| 2021-09-30 | -$19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$110.00M derived: sum of 2 quarters · filed 2022-11-02 | -$19.00M 10-Q · filed 2022-11-02 | $120.00M 10-Q · filed 2021-11-03 | -$89.00M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | -$91.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $110.00M 10-Q · filed 2021-08-05 | -$70.00M derived: sum of 3 quarters · filed 2023-02-22 | -$70.00M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $91.00M 10-Q · filed 2022-05-04 | $21.00M derived: sum of 2 quarters · filed 2023-02-22 | $21.00M derived: sum of 3 quarters · filed 2023-02-22 | $35.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$70.00M derived: sum of 2 quarters · filed 2023-02-22 | -$56.00M derived: sum of 3 quarters · filed 2023-02-22 | -$7.00M 10-K · filed 2023-02-22 | $171.00M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $14.00M derived: sum of 2 quarters · filed 2021-11-03 | $63.00M 10-Q · filed 2021-11-03 | $269.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $63.00M 10-Q · filed 2021-08-05 | $269.00M derived: sum of 3 quarters · filed 2022-02-23 | $284.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $49.00M 10-Q · filed 2021-05-06 | $0.00 10-Q · filed 2020-05-06 | $255.00M derived: sum of 2 quarters · filed 2022-02-23 | $270.00M derived: sum of 3 quarters · filed 2022-02-23 | $301.00M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | $206.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $221.00M derived: sum of 2 quarters · filed 2022-02-23 | $252.00M derived: sum of 3 quarters · filed 2022-02-23 | $434.00M 10-K · filed 2022-02-23 | $384.00M 10-K · filed 2020-02-25 | |||
| 2019-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $46.00M derived: sum of 2 quarters · filed 2020-11-04 | $228.00M 10-Q · filed 2020-11-04 | $198.00M 10-Q · filed 2019-11-05 | $410.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $213.00M 10-Q · filed 2020-08-06 | $302.00M 10-Q · filed 2019-08-06 | $395.00M derived: sum of 3 quarters · filed 2021-02-25 | $301.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $182.00M 10-Q · filed 2020-05-06 | $238.00M 10-Q · filed 2019-05-08 | $364.00M derived: sum of 2 quarters · filed 2021-02-25 | $270.00M derived: sum of 3 quarters · filed 2021-02-25 | $352.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $88.00M derived: sum of 2 quarters · filed 2021-02-25 | $170.00M derived: sum of 3 quarters · filed 2021-02-25 | $190.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$12.00M derived: sum of 2 quarters · filed 2019-11-05 | $8.00M 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $82.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $102.00M 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | $20.00M 10-Q · filed 2019-05-08 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |